Navamedic ASA reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was NOK 120.87 million compared to NOK 121.72 million a year ago. Net loss was NOK 1.58 million compared to net income of NOK 13.17 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.1 NOK | -1.49% | -0.90% | -9.81% |
05-06 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
04-30 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.81% | 54.14M | |
+31.37% | 588B | |
-2.82% | 364B | |
+20.35% | 326B | |
+5.41% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.86% | 167B | |
-0.04% | 161B |
- Stock Market
- Equities
- NAVA Stock
- News Navamedic ASA
- Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024